Skip to main content

Remote Job Finders (RJF)

At JPM26, Experts Try To Look Past the Most Favored Nation ‘Distraction’

Former European Trade Commissioner Phil Hogan and former US Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.

JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff

Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted a 2028 launch. CEO Albert Bourla explained the pharma’s strategy at J.P. Morgan on Monday.

AbbVie Commits $100B in US R&D, Manufacturing, Winning Tariff, Pricing Exemptions

AbbVie has also pledged to participate in TrumpRx and offer many of its products, including Humira, on a direct-to-patient basis. In exchange, the pharma secured exemptions from tariffs and other future pricing directives.
Scroll to top